Chimeric Therapeutics Limited

CHMMF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Operating Activities
Net Income-$10-$13-$26-$16
Dep. & Amort.$1$0$1$1
Deferred Tax$0$0-$2-$7
Stock-Based Comp.$1$0$3$3
Change in WC-$0$4$4-$2
Other Non-Cash$1$1$3$8
Operating Cash Flow-$7-$8-$16-$13
Investing Activities
PP&E Inv.$0$0-$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0-$0-$1
Financing Activities
Debt Repay.$0-$2-$2-$4
Stock Issued$0$12$3$15
Stock Repurch.$0-$1-$0-$1
Dividends Paid$0$0$0$0
Other Fin. Act.$10-$0-$0$0
Financing Cash Flow$10$8$0$10
Forex Effect-$0-$0$0$0
Net Chg. in Cash$3$1-$16-$4
Supplemental Information
Beg. Cash$3$2$18$22
End Cash$6$3$2$18
Free Cash Flow-$7-$8-$16-$14
Chimeric Therapeutics Limited (CHMMF) Financial Statements & Key Stats | AlphaPilot